ABT - Better Coronavirus Stock: Abbott Labs or Hologic?
As of June 18, the number of COVID-19 cases in the United States had ballooned to over 2.2 million. More than 117,000 of those patients have died -- more than a quarter of the pandemic's global death toll.
Now, with the Trump administration intensifying its push to revive economic activity and end the lockdown measures that states have used to stem the disease's spread, it's only getting more important to be able to accurately and widely test people for SARS-CoV-2 infections.
Through testing, healthcare workers will be able to identify and isolate patients with active infections and slow the spread of the disease. Since March, the U.S. Food and Drug Administration (FDA) has authorized more than 100 COVID-19 diagnostic tests for use. Unfortunately, many of these tests face questions regarding their accuracy in real-world settings, despite looking solid when tested in the laboratory.